The global cell based assays market was projected to attain US$ 20.2 billion in 2023. It is anticipated to garner a 6.4% CAGR from 2024 to 2034, and by 2034, the market is likely to attain US$ 40.4 ...

Increasing Accessibility for Flow Cytometry Applications in Emerging and Established Markets Cytek Muse Micro The Cytek® ...

Cellular immunogenicity and immunotoxicity assays help scientists design, validate, and translate therapeutic research into treatments that weaponize the immune response against cancer.

For researchers performing invasion and migration assays, the CIM-Plate 16 used with the xCELLigence RTCA DP Instrument from Roche Applied Science offers a means to monitor cellular responses in ...

The Cell-Based Assays Market is projected to grow from $35.3 billion in 2024 to $56.3 billion by 2029, at a 9.8% CAGR, driven by demand for drug discovery, ADME/toxicity testing, and precision ...

Get inspired to transform your live-cell assays  Accurately counting viable cells in a sample is crucial for various ...

With over 15 years of experience in kinase drug discovery, DiscoverX offers the largest collection of nearly 500 biochemical and cell-based kinase assays. KINOMEscan® technology, our novel kinase ...

Molecular Devices' CellXpress AI streamlines cell culture processes, reducing human error and improving efficiency in drug ...

The global Stem Cell Assays Market is experiencing unprecedented growth, driven by advancements in regenerative medicine, drug discovery, and biotechnology. Valued at US$ 1.6 billion in 2022, the ...